Jae Keith Joung

Title: Innovations and Contributions of Jae Keith Joung

Introduction

Jae Keith Joung is a notable inventor based in Winchester, MA, who has made significant contributions to the field of biotechnology. With a total of three patents to his name, Joung's work focuses on advanced genetic engineering techniques that have the potential to impact medical research and treatment.

Latest Patents

Among his latest patents is the development of transcription activator-like effector (TALE) - lysine-specific demethylase 1 (LSD1) fusion proteins. This innovation involves fusion proteins that comprise a DNA binding domain, such as a TAL effector repeat array or zinc finger array, along with a catalytic domain that catalyzes histone demethylation. Additionally, Joung has patented zinc finger nucleases for the CFTR gene, which provide new zinc finger proteins and nucleases that are particularly useful in repairing the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Career Highlights

Joung has worked with prominent organizations, including The General Hospital Corporation and the University of Iowa Research Foundation. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Some of his notable coworkers include Paul McCray and Morgan Maeder, who have contributed to his research endeavors.

Conclusion

Jae Keith Joung's innovative work in genetic engineering and biotechnology showcases his commitment to advancing medical science. His patents reflect a deep understanding of molecular biology and a dedication to improving health outcomes through technology.